Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (16)

2022

  1. Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 4

  2. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

    Journal of Clinical Medicine, Vol. 11, Núm. 13

2021

  1. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate/severe luts-bph: A subset analysis of the qualiprost study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14

2018

  1. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies

    BJU International, Vol. 122, Núm. 6, pp. 1049-1065

2011

  1. Cost-effectiveness of sacral neuromodulation compared to botulinum neurotoxin a or continued medical management in refractory overactive bladder

    Value in Health, Vol. 14, Núm. 2, pp. 219-228

2010

  1. Overactive bladder: Is there a link to the metabolic syndrome in men?

    Neurourology and Urodynamics, Vol. 29, Núm. 8, pp. 1360-1364

2008

  1. A review of adherence to drug therapy in patients with overactive bladder

    BJU International, Vol. 102, Núm. 7, pp. 774-779

  2. Overactive Bladder and Continence Guidelines: Implementation, inaction or frustration?

    International Journal of Clinical Practice, Vol. 62, Núm. 10, pp. 1588-1593

2007

  1. Analysis of the value of the ICIQ-UI SF questionnaire and stress test in the differential diagnosis of the type of urinary incontinence

    Neurourology and Urodynamics, Vol. 26, Núm. 6, pp. 836-841

  2. Comparación entre el cuestionario "ICIQ-UI short form" y el "King's health questionnaire" como instrumentos de evaluación de la incontinencia urinaria en mujeres

    Actas Urologicas Espanolas, Vol. 31, Núm. 5, pp. 502-510

  3. Design and Validation of a New Screening Instrument for Lower Urinary Tract Dysfunction: The Bladder Control Self-Assessment Questionnaire (B-SAQ)

    European Urology, Vol. 52, Núm. 1, pp. 230-238

2006

  1. Overactive bladder: The importance of new guidance

    International Journal of Clinical Practice, Vol. 60, Núm. 10, pp. 1263-1271

2005

  1. Prevalencia de vejiga hiperactiva en España: Estudio poblacional

    Archivos Espanoles de Urologia, Vol. 58, Núm. 2, pp. 131-138

2000

  1. Validez del cuestionario king's health para la evaluación de la calidad de vida en pacientes con incontinencia urinaria

    Medicina Clinica, Vol. 114, Núm. 17, pp. 647-652

1999

  1. The development and preliminary validation of the IU-4 questionnaire for the clinical classification of urinary incontinence

    Actas urologicas españolas, Vol. 23, Núm. 7, pp. 565-572